Difference between revisions of "Team:SYSU-MEDICINE"

Line 409: Line 409:
 
                 var num = parseInt(id.split("-")[1]);
 
                 var num = parseInt(id.split("-")[1]);
 
                 $(this).children("img").css("z-index", "20");
 
                 $(this).children("img").css("z-index", "20");
−
                iconToCard[num-1].css("display", "block");
+
//                iconToCard[num-1].css("display", "block");
 +
                iconToCard[num-1].fadeIn('fast');
 
             });
 
             });
 
             $(".my-icon").mouseleave(function() {
 
             $(".my-icon").mouseleave(function() {
 
                 var id = $(this).attr("id");
 
                 var id = $(this).attr("id");
 
                 var num = parseInt(id.split("-")[1]);
 
                 var num = parseInt(id.split("-")[1]);
−
                 $(this).children("img").css("z-index", "2");
+
 
−
                 iconToCard[num-1].css("display", "none");
+
//                iconToCard[num-1].css("display", "none");
 +
                 iconToCard[num-1].fadeOut('fast', function() {
 +
                    $(this).children("img").css("z-index", "2");
 +
                 });
 +
 
 
             });
 
             });
 
         });
 
         });

Revision as of 06:06, 13 October 2016

MSCavalry

-----MSCs of
next generation

Inflammatory diseases are an increasing cause of disability and even fatality. Currently, apart from common treatments, MSCs therapy is a promising candidate for curing inflammatory diseases. However, intravascular injected MSCs are criticized for its low homing efficiency and ambiguous distribution in human body.

This year, MSCavalry: MSCs of next generation is coming. SYSU-MEDICINE decide to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.